Objective. To determine the clinical and financial outcomes of a highly structured multidisciplinary care model for patients in an intensive care unit (ICU) who require prolonged mechanical ventilation. The structured model outcomes (protocol group) are compared with the preprotocol outcomes.
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pathophysiology of lung injury and the mediators of the inflammatory response [8] . Alternate modes of mechanical ventilation such as pressure support, pressure control and inverse-ratio ventilation are now widely used [9, 10] . The number of drugs available to treat critically ill patients has increased in the past decade [11, 12] . Numerous monitoring devices such as oximetric pulmonary artery catheters, pulse oximetry and intra-arterial pressure monitoring are now ubiquitous in intensive care units [13] . Despite this energy and expense, it remains largely unproved whether these new approaches or devices have improved outcomes for critically ill adults in the past two decades [14, 15] . Although large multicenter trials and epidemiologic studies suggest that overall mortality rates appear unchanged for many critical disease states over the past several decades, there are substantial variations in mortality rates across ICU after adjustment for severity of illness. The differences in mortality rates are not explained by variations in technology or teaching status [1, 15] . Several authors suggest that the rates may be influenced by the presence or absence of dedicated intensivists [16, 17] . Others propose that the variation in outcomes is best explained by the level of collaborative care and a patient-centered culture [15] .
We define collaborative care in medicine as a coordinated care process that allows practitioners to learn from experience. Effective collaborative care requires minimization of variation to reduce error rates, as well as a system of rules, checks, and balances that evolves over time [18] .
We observed the influence of an evolving collaborative model on the care of critically ill adults requiring prolonged mechanical ventilation at a tertiary referral hospital over a 54-month period. Our observational study was designed to determine whether a collaborative care model, focused on reducing variation and promoting collaborative care for ventilator-dependent patients (VDP), leads to improved medical outcomes and decreases in length of stay and costs.
Subjects and methods
We conducted the study in a 12-bed, mixed medical and surgical ICU at McKay-Dee Hospital, a 380-bed non-teaching tertiary referral hospital. The hospital's Institutional Review Board approved the study and deemed it exempt from informed consent. We identified the patients treated in 1991 through retrospective record review and located them using ventilation patient charges. From 1992 through May 1995 we identified and evaluated patients prospectively. All ICU patients on mechanical ventilation for longer than 72 hours who did not meet the exclusion criteria were enrolled after physician approval, regardless of ability to begin weaning from mechanical ventilation. We excluded patients less than 14 years of age, acutely terminally ill patients (primarily patients meeting institutional brain-death criteria), and patients whose attending physician declined participation. Fourteen patients (4%) were excluded because their physician declined the protocol.
In 1991, a multidisciplinary team was formed that included the principal care givers for patients who required prolonged mechanical ventilation. Team members included a critical care physician, a respiratory therapist, a critical care nurse, a clinical social worker, a quality improvement manager, a physical therapist, a critical care pharmacist, a clinical dietician and a cardiac rehabilitation specialist. The team reviewed the process of care and outcomes in patients who required prolonged mechanical ventilation. Specific problems identified in the care process included sleep deprivation, inconsistent nutritional support, immobility, erratic gastrointestinal bleeding prophylaxis and deep vein thrombosis (DVT) prophylaxis, frequent changes in modes of ventilatory support, ineffective bowel care, inadequate communication with family, and ineffective coordination between medical and ancillary disciplines.
To address the complex process issues we relied on principles of continuous quality improvement (CQI), emphasizing the idea of stable, fixed processes. Effective CQI allows clinicians to measure the impact of process change. CQI establishes an environment where a clinical team applies sequential changes over time for the purpose of continuous improvement as part of routine care delivery. Ideally, CQI permits continuous improvement without the complexity and resources required by randomized controlled trials [19] .
Each team member developed a plan to standardize the care process within the discipline to which this member belonged. The team coordinated areas of care by establishing interdisciplinary guidelines and standardized order sheets. The team met monthly to improve communications and to revise clinical pathways according to feedback from the clinical staff. We held daily formal bedside rounds. Personnel who routinely attended the daily rounds included the critical care physician, clinical dietician, respiratory therapist, pharmacist, and bedside nurse. They held a comprehensive review of all organ systems, laboratory findings, and psychosocial issues. Based on the protocols they determined a multidisciplinary care plan for the day. Less detailed evening rounds were also held on VDP. A social worker completed an initial evaluation within 24 hours of initiation of the protocol. Family conferences were held at least weekly. The team reviewed charts of enrolled patients daily until the patient was removed from the study because of death, successful weaning or transfer to another facility. Successful weaning was defined as removal of the endotracheal tube or as continuous t-piece use for greater than 72 hours. Reinitiation of mechanical ventilation within 72 hours was considered continuation of ventilator dependency for data collection purposes, rather than a new episode of mechanical ventilation.
Data collected on all patients included the ICU length of stay, total hospital length of stay, total charges, total costs, actual reimbursement, and APACHE II scores on ICU admission [20] . We completed financial analysis using actual cumulative cost. This method includes allocating actual variable costs to the specific charge code based on actual utilization. Costs associated with supplies, labor and fixed costs are included [21] . Physician's fees are not included in total cost or charges.
Admission and discharge criteria from the ICU and hospital did not change during the study period. The ICU respiratory therapists and nurses experienced less than a 10% turnover per year during the study. A third critical care physician was added to the staff in late 1992. The ICU continued an open admission policy from 1991 through 1995 but the Intensivist team consulted on greater than 80% of VDP in the preprotocol and protocol eras.
We classified all cases into categories described by Stauffer [22] based on primary diagnosis as follows: postoperative cardiovascular surgery («=115); chronic obstructive pulmonary disease (COPD) (»=11); cardiogenic pulmonary edema (« = 9); pneumonia (« = 44); postoperative general surgery and trauma (« = 155); post cardiac or pulmonary arrest (« = 26); neurologic, operative and non-operative (« = 49); and miscellaneous (« = 60). In addition, we categorized cases by whether a diagnostic related group (DRG) 483 (tracheostomy) designation had been assigned (32% of all VDP).
We constructed logistic regression models [23] based on mortality, including adjustment for severity of illness expressed as APACHE II scores. The models were built using non-protocol cases. We then used these models to compare the mortality for patients treated under the protocol with that of the preprotocol group. We used Fisher's Exact test to determine statistically significant differences between the actual and predicted mortality rates.
We employed linear regression models to test for the presence of significant trends associated with ICU and hospital length of stay, total charges, total costs, and reimbursements during the 42-month protocol period. Regression analysis was used to evaluate differences in preprotocol and protocol trends. We evaluated the same length-of-stay and cost variables for subgroup analysis for survivors and non-survivors.
Results
We evaluated 469 VDP between January 1991 and June 1995. We enrolled into the protocol and studied prospectively 374 eligible, consecutive patients. We also studied 95 consecutive preprotocol patients as historical controls. There were no significant differences in age, mean APACHE II score, or (Tables 1 and 2 ). When examined within diagnostic category, the mortality rates showed no significant differences between protocol and preprotocol patients ( Table  2) . Average ICU length of stay and overall hospital length of stay decreased significantly for survivors in the protocol versus the preprotocol groups (Table 1) . Overall distribution of patients within diagnostic categories did not vary significandy in the preprotocol to protocol groups (Table 3) .
Marked reductions in costs and charges were also associated with use of the care process (Table 4) . Total hospital average charges per episode decreased significandy (/ > <0.001). Because of decreased total costs, actual net average loss per case decreased from an average loss of US$15 400 in the preprotocol group to a loss of US$7900 in the protocol patient survivor's group (P=0.05). Within individual diagnostic categories, the postoperative general surgery and trauma patients demonstrated significant reductions in charges, cost, hospital length of stay and ICU length of stay (Table 2) . There was no significant difference in the percentage of these patients in the preprotocol period versus the protocol period. A significant reduction in ICU length of stay for neuro patients was associated with protocol use.
A linear regression model illustrates the ongoing influence of the multidisciplinary approach. Trend analysis of ICU length of stay, hospital length of stay, charges, costs, and average net (actual reimbursement -total) cost showed significant ongoing reductions in all categories (Figures 1-5 ). The reduction in cost per case for survivors was in excess of US$20 000 based on comparison of average costs for the first 6 months of the study with those of the final 6 months. This reduction was also seen for non-survivors. Given the average of 125 VDP per year at our institution, this result suggests a possible decrease of US$2 500 000 per year in resource consumption for VDP in 1995 compared with 1991 at this hospital alone.
Multiple regression analysis of cost, charges, and length of stay trends demonstrate no significant difference in the trends for preprotocol and protocol groups (JP>0.05).
Discussion
The total number of VDP per day in the USA is in excess of 11 000 [24] . Mortality rates for VDP appear not to have changed in the past 20 years [4, 25] . Various researchers have noted the apparent inability of newer technologies to influence outcomes [25, 26] . However, marked variations in mortality rates across ICU do exist. These variations remain after we control for differences in severity of illness and disease classification. Knaus and colleagues described ratios of predicted to observed mortality in ICU ranging from 1:0.59 to 1:1.58 [15] . While mortality rates for VDP have not changed, the costs for caring for these patients may have increased three-fold in the past decade [2] . The use of new technologies has contributed to escalating costs [27] . Sedation drugs and paralytics, including midazolam, propofol, and atracurium, may cost US$1000 per day when used as continuous infusions in VDP [28] . Antibiotic options have grown dramatically in number and cost [29, 30] . Numerous other cost centers in the ICU include laboratory testing, radiology, specialty beds, and invasive monitoring equipment [27] . The cost of critical care personnel (nurses, respiratory therapists, technicians) remains the largest single cost factor [27] . Few data are available on the impact of physicians' professional fees on overall costs in the ICU [7J.
The literature cites unchanging mortality rates for VDP, while ICU costs for this patient subset continue to escalate. The mortality rate (21%) for VDP in our preprotocol group was already substantially lower than that generally described in the literature, perhaps because of the use of full-time intensivists [4] . Thus, our principal goals in developing the collaborative model were to reduce length of stay and resource consumption while maintaining a low mortality rate. We focused on the resources used by survivors until their discharge from hospital. ICU and hospital lengths of stay were not appreciably different for non-survivors in the preprotocol compared with the protocol group.
VDP consume more resources than any other patient group in many hospitals [4] . Since the advent of DRG in 1982, VDP often create financial deficits for hospitals, in that costs typically far exceed third-party reimbursement [31] . Thus, we scrutinized each aspect of the care process for VDP to estimate its potential contribution to lowering mortality rates and to decreasing costs and length of stay (see Appendix). Our care process for VDP emphasizes protocol use and coordinated care. Recurrent process errors in the ICU substantially increase morbidity and mortality [32, 33] . Published experience with rigorous protocols in the ICU setting is limited. Studies involving a protocol for thrombolytics in acute myocardial infarction and a computer-driven protocol controling mechanical ventilation in patients with acute respiratory distress syndrome (ARDS) suggest that standardizing care may improve outcomes [34, 35] . Protocols may reduce error by simplifying a process, by decreasing the frequency of potentially harmful therapeutic decisions and by improving communication within the health care team [36] .
Most studies that evaluate VDP focus on weaning parameters and on ventilatory weaning modes [37, 38] . No one parameter or mode has emerged as superior or has gained widespread acceptance [39] . Other studies on collaborative weaning teams consisting of a designated physician and respiratory therapist indicate that a dedicated team approach to VDP reduces length of stay and costs and may result in fewer reintubations [40] . Specialized postacute care units have also been developed to manage VDP. Several of these specialized units have reported a reduction in resource use associated with collaborative care [41, 42] .
Our analysis has several limitations. A randomized doubleblind controlled trial provides the highest level of scientific evidence for clinical trials. However, a quasi-experimental design with retrospective or non-randomized concurrent control may be the best model available for use in studying multiple simultaneous changes in a care process. For example, with our VDP model, the pattern of care promoted by the model quickly became the standard of care for both protocol and non-protocol patients, making randomization ineffective. Changes in the process of care independent of the model that may have occurred during the 4-year study period are difficult to quantify and control. The addition of a third intensivist during the protocol phase may have impacted care. However, the intensivist philosophy of providing bedside care with a primary focus on team approach remained constant. Furthermore, it is difficult to determine the impact of specific process changes on length of stay and cost.
The trend of decreasing cost, charges, and length of stay prior to the implementation of the new process does not significantly differ from the protocol trend. During the preprotocol period the physicians and care givers began analysis of variations in care and identified a need for standards, protocols, and teams. The preprotocol trends towards improvements in outcomes may be explained by a Hawthorne effect. Additionally, the study suffers from lack of concurrent controls. It is possible that secular trends may account for our changes in outcomes. However, at our hospital, the improvement in outcomes were achieved within the context of developing collaborative teams relying heavily on protocol use. We are also unaware of any literature documenting systematic decreases in costs of care for this patient group nationwide during this time period.
Costs associated with the protocol teams and patient care review work were not included in the financial analysis. The 15-member team met together for one hour each month creating a modest incremental cost to the hospital to support employees paid by the hour. However, there were no other apparent additional resources associated with implementing the protocol. This suggests that our collaborative process may be an efficient mechanism to implement changes.
Limitations of using APACHE II scoring for risk stratification have been described [43] . Validated positive predictive values of APACHE II scores are 70% whereas the validated negative predictive value is 87.9%. These values are based on a 50% decision criterion (if risk is >50%, predict death; if <50%, predict survival). APACHE II is also subject to selection and lead-time bias. The APACHE II prognostic system has been used widely to stratify patients according to risk of hospital mortality and for case-mix control [15] .
The use of in-hospital mortality as an outcome measure may be incomplete without inclusion of outpatient lengthof-survival and quality-of-life markers. Yet, few studies incorporate out-of-hospital survival and quality-of-life markers as outcome measures for ICU patient populations [44] . Future studies may incorporate these outpatient measurements to identify the overall influence of changes in critical care.
Global costs of caring for a VDP from the beginning of ventilator dependence until full recovery or death also are not included in this analysis. A study investigating the total cost of VDP to the health care system will be enlightening. Although the protocol was associated with significantly decreased costs, hospital costs remained higher than reimbursements. Other institutions report a substantial gap between costs and reimbursement for VDP [31] . The cumulative data suggest that third-party payers, such as Medicare, need to re-evaluate payment made to hospitals for the management of episodes of prolonged mechanical ventilation.
Summary
Our experience suggests that a team approach emphasi2ing collaborative care and dynamic clinical guidelines for patients requiring prolonged mechanical ventilation substantially reduces length of stay and costs. Employment of fundamental principles of CQI was associated with ongoing improvement. Patient medical outcomes, as reflected by in-hospital mortality rates, remained unchanged.
The protocols that members of the team developed for nursing pharmacy, respiratory therapy, occupational therapy, physical therapy, cardiac rehabilitation, nutrition, and social work are extensive and continue to evolve. We provide here a brief description of the key clinical processes addressed by the multidisciplinary team.
DVT prophylaxis
Patients receiving prolonged mechanical ventilation are at high risk for thromboembolic disorders [45] . Subcutaneous heparin and compression stockings each reduce morbidity and mortality in patients at risk. Surveys of US physicians' practice patterns reveal use of proven modalities of DVT prophylaxis in less than 40% of high-risk patients [46] . Preventable fatal pulmonary emboli may be the most common cause of preventable hospital deaths [47] . All our VDP received DVT prophylaxis.
Gl prophylaxis
The ability of H-2 blockers and sucralfate to reduce mortality and morbidity in the ICU setting remains controversial [48, 49] . A recent study suggests a 50% decrease in significant bleeding with H-2 blockers in critically ill patients [50] . Other studies warn of increased pneumonia in VDP with the use of H-2 blockers [51] . Two investigators' studies did not confirm this increased risk [52] . Thus, the influence of our routine use of H-2 blockers or sucralfate in nearly all VDP is unknown. The protocol required all patients be placed on GI prophylaxis.
Physical therapy
Few investigators have studied the effects of physical therapy on VDP. Our VDP protocol included consultation with a full-time ICU-based physical therapy team that provided early activity intervention. Frequently, our therapists ambulated VDP with assistance, even when patients had pulmonary artery catheters, chest tubes, and arterial lines in place. A study evaluating patients with severe COPD suggests that supervised conditioning improves overall muscle tone and endurance [53] . The influence of bed rest on respiratory recovery and overall muscle strength is evident from literature describing prolonged neuromuscular blockade and protracted weakness and prolonged mechanical ventilator dependency associated with use of steroids and of non-depolarizing agents in the ICU [54] . Evidence from patients recovering from fractured hips in geriatric acute care programs suggests that early aggressive physical therapy may reduce length of hospital stay in fragile patients [55] .
Nutrition
Avoidance of negative nitrogen balance by supplementation with adequate protein is associated with fewer complications in critically ill patients [56] . Our protocol provided early nutritional support with jejunal feeding tubes, using immuneenhancing formulae. A recent study comparing immuneenhancing formulae to standard formulae demonstrated reductions in length of stay with the former [57] . More than 70% of our VDP received enteral nutrition within 24 hours after initiation of mechanical ventilation ( Figure 6 ). Early enteral feeding reduced their reliance on total parenteral nutrition (TPN). Enteral nutrition costs less per day than does TPN (at our institution it results in an estimated cost reduction of US$180 per day). Furthermore, TPN may increase infectious complications [58] . We monitored serum prealbumin levels and C-reactive protein levels twice weekly to help define nutrition requirements. Non-responders were defined as patients in whom prealbumin levels were not rising, yet C-reactive protein levels (a measure of inflammatory stress) were falling. Non-responders underwent metabolic studies or 24-hour urine collections for urine urea nitrogen.
Sleep deprivation
Severe alterations in sleep patterns are common in the ICU and contribute to agitation, delirium, and fatigue. Noise and other recurrent stimulations may thus contribute to morbidity and mortality in the critically ill [59] . Our protocol encouraged uninterrupted sleep at night by minimizing night-time procedures, tests, and visiting. Sedation regimens were aimed at 
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Figure 6
Time from intubation to placement of feeding tube January-June 1995 (# = 67) achieving several periods of at least 90 minutes of unbroken sleep per night.
Critical care pharmacists
In the past 15 years, several studies have described the influence of dedicated critical care pharmacists on improving care and reducing costs [60] . As part of our process, a fulltime pharmacist attends the ICU 7 days per week. These pharmacists tracked drug-drug interactions, educated the ICU staff, checked on drug levels, helped staff to develop protocols, estimated dosing requirements, and made recommendations on sedation, antimicrobial, and other regimens. The pharmacists also encouraged clinicians to switch, when possible, from i.v. to an enteral route of drug administration. Changing from i.v. to p.o. administration of agents such as the quinolones, ben2odiapines, H-2 blockers, and fluconazole reduces costs [61] .
Critical care physicians
Less than 70% of US ICU have a full-time medical director and only 44% of ICU directors are certified in critical care. Twelve percent of US ICU have admissions authorized by an ICU director [62] . The infrequent use of full-time intensivists in this country is surprising in light of studies indicating substantial reductions in morbidity and mortality when an intensivist team is used [16, 17] . Our program consists of three full-time fellowship-trained, board-certified intensivists who work at one facility.
